Hostname: page-component-cb9f654ff-r5d9c Total loading time: 0 Render date: 2025-08-13T22:52:56.875Z Has data issue: false hasContentIssue false
  • English
  • Français

Leucopenia y neutropenia inducidas por risperidona: un caso clínico

Published online by Cambridge University Press:  12 May 2020

M. Sluys ,
Y. Güzelcan ,
G. Casteelen  and
L. de Haan
M. Sluys
Affiliation:
Departamento de Psiquiatría, Centro Médico Académico, Universidad de Amsterdam, P. O. Boz 22700, 1100DE Amsterdam, Países Bajos
Y. Güzelcan
Affiliation:
Departamento de Psiquiatría, Centro Médico Académico, Universidad de Amsterdam, P. O. Boz 22700, 1100DE Amsterdam, Países Bajos
G. Casteelen
Affiliation:
Departamento de Psiquiatría, Centro Médico Académico, Universidad de Amsterdam, P. O. Boz 22700, 1100DE Amsterdam, Países Bajos
L. de Haan
Affiliation:
Departamento de Psiquiatría, Centro Médico Académico, Universidad de Amsterdam, P. O. Boz 22700, 1100DE Amsterdam, Países Bajos
Get access

Abstract

An abstract is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'

Information

Type
Caso clínico
Information
European Psychiatry (Ed. Española) , Volume 11 , Issue 4 , May 2004 , pp. 269
Copyright
Copyright © European Psychiatric Association 2004

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Article purchase

Temporarily unavailable

References

Bibliografía

Mahmood, T., Silverstone, T., Spittle, B., Rispendone appears to be safe in patients with antipsychotic-induced blood dyscrasias. Int Clin Psychopharmacol 1996;11:53–4.CrossRefGoogle ScholarPubMed
Dernovsek, Z., Tavcar, R., Risperidone-induced leucopenia and nentropenia. Br J Psychiatry 1997;171:393–4.CrossRefGoogle Scholar
Finkel, B., Lemer, A.G., Oyffe, I., Sigal, M., Risperidone-associated agranulocytosis. Am J Psychiatry 1998;155:6.Google ScholarPubMed
Bondolfi, G., Morena, P., Dascal, D., Bertschy, G., Risperidone and reversible neutropenia: a negative rechallenge. Eur Neuropsychopharmacol 1996;6:257.CrossRefGoogle ScholarPubMed
Hong, X., Wang, X., Agranulocytosis and neutropenia with typical and atypical neuroleptics. Am J Psychiatry 2001;158:1736–7.CrossRefGoogle ScholarPubMed
Godleski, L.S., Semyak, MJ., Agranulocytosis after addition of risperidone to clozapine treatment. Am J Psychiatry 1996;153:735–6.Google ScholarPubMed